Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach

P. Ticha, M. Wu, O. Mestak, A. Sukop

. 2022 ; 46 (1) : 71-82. [pub] 20210930

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011081

Grantová podpora
AZV 17-29084A grantová agentura české republiky

E-zdroje Online Plný text

NLK ProQuest Central od 2002-11-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2002-11-01 do Před 1 rokem

BACKGROUND: Breast reconstructive surgery is often a multistage process. The aim was to understand which factors might increase the number of follow-up surgeries and the length of time required to complete the reconstruction process. METHODS: A cross-sectional analysis was performed. Clinical data of 110 patients who underwent delayed postmastectomy breast reconstruction with a 5-year examination period were reviewed retrospectively. Impact of clinical risk factors, oncological therapy, and reconstruction approach on the number of surgeries and the length of required time was analyzed. Mann-Whitney U test and Kruskal-Wallis rank sum test were used. RESULTS: In patients undergoing perioperative hormone therapy, an average of 2.9 surgeries and length of 20.2 months were required compared to 2.3 surgeries and 14.0 months in patients without hormone therapy (P = 0.003; P = 0.005). Previous abdominal surgery was associated with an increased number of breast reconstruction stages of 3.1 per patient (P = 0.056) and a longer reconstruction time of 23.0 months (P = 0.050). Patients undergoing nipple reconstruction or implant revision required an increased number of surgeries (P < 0.001; P = 0.012) and a longer reconstruction time (P = 0.002; P < 0.001). Contralateral breast surgery and flap revision were associated only with an increased number of surgeries (P < 0.001; P < 0.001). CONCLUSION: Perioperative hormone therapy was associated with a significantly higher number of surgeries and duration of time required to complete the reconstruction process. The highest increase in the number of surgeries was in patients with flap revision including anastomosis revision and necrectomy. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011081
003      
CZ-PrNML
005      
20230222110646.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00266-021-02580-1 $2 doi
035    __
$a (PubMed)34595599
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Tichá, Pavla $u Department of Plastic Surgery, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University in Prague, Srobarova 50, Praha 10, 10034, Czech Republic $u Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, 1651 Page Mill Road, Palo Alto, CA, 94304, USA $7 xx0282380
245    10
$a Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach / $c P. Ticha, M. Wu, O. Mestak, A. Sukop
520    9_
$a BACKGROUND: Breast reconstructive surgery is often a multistage process. The aim was to understand which factors might increase the number of follow-up surgeries and the length of time required to complete the reconstruction process. METHODS: A cross-sectional analysis was performed. Clinical data of 110 patients who underwent delayed postmastectomy breast reconstruction with a 5-year examination period were reviewed retrospectively. Impact of clinical risk factors, oncological therapy, and reconstruction approach on the number of surgeries and the length of required time was analyzed. Mann-Whitney U test and Kruskal-Wallis rank sum test were used. RESULTS: In patients undergoing perioperative hormone therapy, an average of 2.9 surgeries and length of 20.2 months were required compared to 2.3 surgeries and 14.0 months in patients without hormone therapy (P = 0.003; P = 0.005). Previous abdominal surgery was associated with an increased number of breast reconstruction stages of 3.1 per patient (P = 0.056) and a longer reconstruction time of 23.0 months (P = 0.050). Patients undergoing nipple reconstruction or implant revision required an increased number of surgeries (P < 0.001; P = 0.012) and a longer reconstruction time (P = 0.002; P < 0.001). Contralateral breast surgery and flap revision were associated only with an increased number of surgeries (P < 0.001; P < 0.001). CONCLUSION: Perioperative hormone therapy was associated with a significantly higher number of surgeries and duration of time required to complete the reconstruction process. The highest increase in the number of surgeries was in patients with flap revision including anastomosis revision and necrectomy. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
650    12
$a nádory prsu $x etiologie $x chirurgie $7 D001943
650    _2
$a průřezové studie $7 D003430
650    _2
$a estetika $7 D004954
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    12
$a mamoplastika $x škodlivé účinky $x metody $7 D016462
650    _2
$a mastektomie $x metody $7 D008408
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wu, Meagan $u Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, 1651 Page Mill Road, Palo Alto, CA, 94304, USA
700    1_
$a Mestak, Ondrej $u Department of Plastic Surgery, Bulovka Hospital, 1st Medical Faculty of Charles University in Prague, Budinova 2, Prague 8, 14800, Czech Republic
700    1_
$a Sukop, Andrej $u Department of Plastic Surgery, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University in Prague, Srobarova 50, Praha 10, 10034, Czech Republic. andrej@sukop.cz $1 https://orcid.org/0000000159245123
773    0_
$w MED00005691 $t Aesthetic plastic surgery $x 1432-5241 $g Roč. 46, č. 1 (2022), s. 71-82
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34595599 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20230222110641 $b ABA008
999    __
$a ok $b bmc $g 1788930 $s 1162279
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 46 $c 1 $d 71-82 $e 20210930 $i 1432-5241 $m Aesthetic plastic surgery $n Aesthetic Plast Surg $x MED00005691
GRA    __
$a AZV 17-29084A $p grantová agentura české republiky
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...